0.0230
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 75.18k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| The K2 Principal Fund L.P. 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 0.12 per share. | Direct | 28,226 | Nov 29, 2021 |
Related Tickers
KMSTF Kadimastem Ltd
0.6404
-90.00%
ATBPF Antibe Therapeutics Inc.
0.2160
0.00%
OTLC Oncotelic Therapeutics, Inc.
0.0300
+7.14%
APLMW Apollomics, Inc.
0.0110
0.00%
WF6.F MindBio Therapeutics Corp.
0.0180
+45.16%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0213
+0.95%
PTIXW Protagenic Therapeutics, Inc.
0.0040
0.00%
KLTOW Klotho Neurosciences, Inc.
0.0400
+13.96%
NLSPW NLS Pharmaceutics AG
0.0125
+1.63%
DRMAW Dermata Therapeutics, Inc.
0.0297
+2.41%